| scholarly article | Q13442814 |
| P2093 | author name string | L. X. Cubeddu | |
| I. S. Hoffmann | |||
| P2860 | cites work | Combination antiemetics for cisplatin chemotherapy | Q34686969 |
| 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret | Q35756396 | ||
| Methodology of antiemetic trials: a review | Q37764625 | ||
| Neuropharmacology of emesis induced by anti-cancer therapy. | Q39583751 | ||
| Efficacy of Ondansetron (Gr 38032F) and the Role of Serotonin in Cisplatin-Induced Nausea and Vomiting | Q42136434 | ||
| Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs | Q42371534 | ||
| The emetic activity of centrally administered cisplatin in cats and its antagonism by zacopride | Q45069201 | ||
| Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Re | Q51746449 | ||
| Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients. | Q51831525 | ||
| Nausea and vomiting as major complications of cancer chemotherapy. | Q52096253 | ||
| Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. | Q53768861 | ||
| The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret | Q68279695 | ||
| Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species | Q69587183 | ||
| Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting | Q70177918 | ||
| Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy | Q70370019 | ||
| Dexamethasone mimicks the antimotion sickness effects of amphetamine and scopolamine | Q74466403 | ||
| Observations on the release and turnover rate of 5-hydroxytryptamine in the gastrointestinal tract | Q79226261 | ||
| Tissue 5-hydroxytryptamine and urinary 5-hydroxyindoleacetic acid after partial or total removal of the gastro-intestinal tract in the rat | Q80318368 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 691-697 | |
| P577 | publication date | 1993-08-01 | |
| P1433 | published in | The Journal of Clinical Pharmacology | Q7743562 |
| P1476 | title | Participation of serotonin on early and delayed emesis induced by initial and subsequent cycles of cisplatinum-based chemotherapy: effects of antiemetics | |
| Participation of Serotonin on Early and Delayed Emesis Induced by Initial and Subsequent Cycles of Cisplatinum‐Based Chemotherapy: Effects of Antiemetics | |||
| P478 | volume | 33 |
| Q71709783 | 5-Hydroxyindoleacetic acid excretion following combination chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil plus ondansetron compared to ondansetron alone |
| Q35612563 | A New Strategy Using Rikkunshito to Treat Anorexia and Gastrointestinal Dysfunction |
| Q57278975 | An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting |
| Q38264663 | Clinical application of ghrelin in the field of surgery |
| Q33495298 | Comparative adverse effect profiles of platinum drugs. |
| Q71584601 | Efficacy and safety of ondansetron in pediatric patients undergoing bone marrow transplantation |
| Q37902946 | Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients |
| Q34298900 | Ondansetron: a review of its use as an antiemetic in children |
| Q41348442 | Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds |
| Q36081722 | Plasma chromogranin A marks emesis and serotonin release associated with dacarbazine and nitrogen mustard but not with cyclophosphamide-based chemotherapies |
| Q28379389 | Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study |
| Q41878959 | The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret |
| Q73193781 | The actions of ondansetron and dexamethasone to antagonise cisplatin-induced emesis in the ferret |
| Q36080511 | Treatment with para-chlorophenylalanine antagonises the emetic response and the serotonin-releasing actions of cisplatin in cancer patients |
| Q48792646 | X-ray analysis of the effect of the 5-HT3 receptor antagonist granisetron on gastrointestinal motility in rats repeatedly treated with the antitumoral drug cisplatin |
Search more.